Fecal calprotectin: A promising readily available tool associated with outcome in patients with cirrhosis
United European Gastroenterology Journal · 2025-04 · 13 (3) · 349-350
DOI: 10.1002/ueg2.12640 ↗Kurz gefasst
Editorial in der Zeitschrift United European Gastroenterology Journal, 2024-11. Verfasst von Florent Artru. Beteiligte Einrichtung: Liver Department, Rennes University Hospital, Rennes, Bretagne, France. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Liver Department, Rennes University Hospital, Rennes, Bretagne, France.
- NuMeCan Institute, Inserm U1241, Rennes Liver Failure Group (RELIEF), University of Rennes, Rennes, Bretagne, France.
ORCID-Profile: Florent Artru
Zitieren
APA
Artru, F. (2025). Fecal calprotectin: A promising readily available tool associated with outcome in patients with cirrhosis. United European Gastroenterology Journal, 13(3), 349-350. https://doi.org/10.1002/ueg2.12640
Vancouver
Artru F. Fecal calprotectin: A promising readily available tool associated with outcome in patients with cirrhosis. United European Gastroenterology Journal. 2025;13(3):349-350. doi:10.1002/ueg2.12640
BibTeX
@article{Artru2025,
author = {Artru, Florent},
title = {Fecal calprotectin: A promising readily available tool associated with outcome in patients with cirrhosis},
journal = {United European Gastroenterology Journal},
year = {2025},
volume = {13},
number = {3},
pages = {349--350},
doi = {10.1002/ueg2.12640}
}
EUVIMED